We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$847M
Cap. Flow %
6.54%
Top 10 Hldgs %
18.23%
Holding
2,527
New
188
Increased
1,360
Reduced
792
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 4.91%
3 Healthcare 4.18%
4 Consumer Discretionary 3.53%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNC icon
451
PNC Financial Services
PNC
$101B
$5.23M 0.04%
32,777
+1,105
+3% +$166K
DWAS icon
452
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$445M
$5.21M 0.04%
91,273
+15,633
+21% +$826K
CCI icon
453
Crown Castle
CCI
$31.3B
$5.2M 0.04%
36,593
+3,362
+10% +$459K
PPL
454
PPL Corp
PPL
$26.5B
$5.2M 0.04%
144,994
+15,513
+12% +$520K
ADRE
455
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$5.19M 0.04%
+117,467
New +$4.85M
IDV icon
456
iShares International Select Dividend ETF
IDV
$8.52B
$5.18M 0.04%
154,436
+29,311
+23% +$942K
TECH icon
457
Bio-Techne
TECH
$11.2B
$5.18M 0.04%
94,340
+80,152
+565% +$4.21M
AXP icon
458
American Express
AXP
$230B
$5.17M 0.04%
41,507
+1,856
+5% +$222K
FNX icon
459
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.41B
$5.16M 0.04%
71,163
+736
+1% +$51.5K
HBAN icon
460
Huntington Bancshares
HBAN
$35.9B
$5.1M 0.04%
338,486
+22,299
+7% +$327K
IYW icon
461
iShares US Technology ETF
IYW
$25.2B
$5.09M 0.04%
87,556
-8,620
-9% -$469K
SPLB icon
462
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.18B
$5.07M 0.04%
168,456
-13,998
-8% -$419K
FRN
463
DELISTED
Invesco Frontier Markets ETF
FRN
$5.06M 0.04%
354,353
-8,221
-2% -$116K
VPL icon
464
Vanguard FTSE Pacific ETF
VPL
$8.42B
$5.03M 0.04%
72,323
+1,637
+2% +$112K
MAIN icon
465
Main Street Capital
MAIN
$5.52B
$5.03M 0.04%
116,571
+7,428
+7% +$318K
HFRO
466
Highland Opportunities and Income Fund
HFRO
$403M
$5.02M 0.04%
404,076
+25,366
+7% +$305K
SMDV icon
467
ProShares Russell 2000 Dividend Growers ETF
SMDV
$705M
$5M 0.04%
80,937
+8,976
+12% +$543K
UHS icon
468
Universal Health Services
UHS
$9.94B
$4.98M 0.04%
34,683
+2,738
+9% +$390K
VTR icon
469
Ventas
VTR
$44.6B
$4.97M 0.04%
86,159
+7,519
+10% +$472K
HISF icon
470
First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF
HISF
$98.8M
$4.97M 0.04%
96,596
+8,249
+9% +$419K
GSK icon
471
GSK
GSK
$102B
$4.93M 0.04%
83,959
+2,697
+3% +$150K
SMLV icon
472
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$259M
$4.93M 0.04%
49,279
+9,265
+23% +$905K
ISRG icon
473
Intuitive Surgical
ISRG
$142B
$4.92M 0.04%
24,987
-2,253
-8% -$422K
LDOS icon
474
Leidos
LDOS
$17.7B
$4.91M 0.04%
50,185
+6,223
+14% +$548K
WY icon
475
Weyerhaeuser
WY
$18B
$4.89M 0.04%
161,773
+5,198
+3% +$151K

Similar funds

Cambridge Investment Research Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Cambridge Investment Research Advisors held 2,527 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors deployed $847M of net new capital in Q4 2019, opening 188 new positions and adding to 1,360 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $23.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2019 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.
  • Cambridge Investment Research Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q4 2019, an estimated $38.2M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2019 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $23.2M.
  • Cambridge Investment Research Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $13.9M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $13B portfolio in Q4 2019.
  • Cambridge Investment Research Advisors opened 188 new positions and closed 124 in Q4 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.